The deubiquitylase USP2 regulates the LDLR pathway by counteracting the E3-ubiquitin ligase IDOL
The deubiquitylase USP2 regulates the LDLR pathway by counteracting the E3-ubiquitin ligase IDOL
Rationale: the low-density lipoprotein (LDL) receptor (LDLR) is a central determinant of circulating LDL-cholesterol and as such subject to tight regulation. Recent studies and genetic evidence implicate the inducible degrader of the LDLR (IDOL) as a regulator of LDLR abundance and of circulating levels of LDL-cholesterol in humans. Acting as an E3-ubiquitin ligase, IDOL promotes ubiquitylation and subsequent lysosomal degradation of the LDLR. Consequently, inhibition of IDOL-mediated degradation of the LDLR represents a potential strategy to increase hepatic LDL-cholesterol clearance.
Objective: to establish whether deubiquitylases counteract IDOL-mediated ubiquitylation and degradation of the LDLR.
Methods and results: using a genetic screening approach, we identify the ubiquitin-specific protease 2 (USP2) as a post-transcriptional regulator of IDOL-mediated LDLR degradation. We demonstrate that both USP2 isoforms, USP2-69 and USP2-45, interact with IDOL and promote its deubiquitylation. IDOL deubiquitylation requires USP2 enzymatic activity and leads to a marked stabilization of IDOL protein. Paradoxically, this also markedly attenuates IDOL-mediated degradation of the LDLR and the ability of IDOL to limit LDL uptake into cells. Conversely, loss of USP2 reduces LDLR protein in an IDOL-dependent manner and limits LDL uptake. We identify a tri-partite complex encompassing IDOL, USP2, and LDLR and demonstrate that in this context USP2 promotes deubiquitylation of the LDLR and prevents its degradation.
Conclusions: our findings identify USP2 as a novel regulator of lipoprotein clearance owing to its ability to control ubiquitylation-dependent degradation of the LDLR by IDOL.
Animals, Cholesterol, LDL/metabolism, Endopeptidases/genetics, Enzyme Stability, HEK293 Cells, HeLa Cells, Hep G2 Cells, Humans, Mice, Knockout, Multienzyme Complexes, Protein Binding, Proteolysis, RNA Interference, Receptors, LDL/genetics, Transfection, Ubiquitin Thiolesterase, Ubiquitin-Protein Ligases/deficiency, Ubiquitination
410-419
Nelson, Jessica Kristine
7dc3f0c8-5a67-4467-a332-efd560a0630b
Sorrentino, Vincenzo
f0cb3b5b-3a17-4ab3-ab65-180a7ee50d8a
Avagliano Trezza, Rossella
699a869f-d6cf-4496-a16f-9e0a8ec9e215
Heride, Claire
fd5a19d5-144a-4c60-a9de-7b37e19b06b3
Urbe, Sylvie
22a9ae82-2692-47b6-9697-fb6f2f28dd30
Distel, Ben
723d16f8-7313-48f9-86ee-a34660089e50
Zelcer, Noam
c5eff664-b107-4a7c-9823-11ccb8149fbc
5 February 2016
Nelson, Jessica Kristine
7dc3f0c8-5a67-4467-a332-efd560a0630b
Sorrentino, Vincenzo
f0cb3b5b-3a17-4ab3-ab65-180a7ee50d8a
Avagliano Trezza, Rossella
699a869f-d6cf-4496-a16f-9e0a8ec9e215
Heride, Claire
fd5a19d5-144a-4c60-a9de-7b37e19b06b3
Urbe, Sylvie
22a9ae82-2692-47b6-9697-fb6f2f28dd30
Distel, Ben
723d16f8-7313-48f9-86ee-a34660089e50
Zelcer, Noam
c5eff664-b107-4a7c-9823-11ccb8149fbc
Nelson, Jessica Kristine, Sorrentino, Vincenzo, Avagliano Trezza, Rossella, Heride, Claire, Urbe, Sylvie, Distel, Ben and Zelcer, Noam
(2016)
The deubiquitylase USP2 regulates the LDLR pathway by counteracting the E3-ubiquitin ligase IDOL.
Circulation Research, 118 (3), .
(doi:10.1161/CIRCRESAHA.115.307298).
Abstract
Rationale: the low-density lipoprotein (LDL) receptor (LDLR) is a central determinant of circulating LDL-cholesterol and as such subject to tight regulation. Recent studies and genetic evidence implicate the inducible degrader of the LDLR (IDOL) as a regulator of LDLR abundance and of circulating levels of LDL-cholesterol in humans. Acting as an E3-ubiquitin ligase, IDOL promotes ubiquitylation and subsequent lysosomal degradation of the LDLR. Consequently, inhibition of IDOL-mediated degradation of the LDLR represents a potential strategy to increase hepatic LDL-cholesterol clearance.
Objective: to establish whether deubiquitylases counteract IDOL-mediated ubiquitylation and degradation of the LDLR.
Methods and results: using a genetic screening approach, we identify the ubiquitin-specific protease 2 (USP2) as a post-transcriptional regulator of IDOL-mediated LDLR degradation. We demonstrate that both USP2 isoforms, USP2-69 and USP2-45, interact with IDOL and promote its deubiquitylation. IDOL deubiquitylation requires USP2 enzymatic activity and leads to a marked stabilization of IDOL protein. Paradoxically, this also markedly attenuates IDOL-mediated degradation of the LDLR and the ability of IDOL to limit LDL uptake into cells. Conversely, loss of USP2 reduces LDLR protein in an IDOL-dependent manner and limits LDL uptake. We identify a tri-partite complex encompassing IDOL, USP2, and LDLR and demonstrate that in this context USP2 promotes deubiquitylation of the LDLR and prevents its degradation.
Conclusions: our findings identify USP2 as a novel regulator of lipoprotein clearance owing to its ability to control ubiquitylation-dependent degradation of the LDLR by IDOL.
This record has no associated files available for download.
More information
e-pub ahead of print date: 14 December 2015
Published date: 5 February 2016
Keywords:
Animals, Cholesterol, LDL/metabolism, Endopeptidases/genetics, Enzyme Stability, HEK293 Cells, HeLa Cells, Hep G2 Cells, Humans, Mice, Knockout, Multienzyme Complexes, Protein Binding, Proteolysis, RNA Interference, Receptors, LDL/genetics, Transfection, Ubiquitin Thiolesterase, Ubiquitin-Protein Ligases/deficiency, Ubiquitination
Identifiers
Local EPrints ID: 505362
URI: http://eprints.soton.ac.uk/id/eprint/505362
ISSN: 0009-7330
PURE UUID: 5f5c56f0-188a-49a0-9e88-aec5fd9c48d5
Catalogue record
Date deposited: 07 Oct 2025 16:45
Last modified: 08 Oct 2025 02:17
Export record
Altmetrics
Contributors
Author:
Jessica Kristine Nelson
Author:
Vincenzo Sorrentino
Author:
Rossella Avagliano Trezza
Author:
Claire Heride
Author:
Sylvie Urbe
Author:
Ben Distel
Author:
Noam Zelcer
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics